ArticleWorld journal of gastroenterology2019
Submucosal tunneling endoscopic resection: An effective and safe therapy for upper gastrointestinal submucosal tumors originating from the muscularis propria layer.
Article in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- Submucosal Tunneling Endoscopic Resection Versus Endoscopic Submucosal Dissection for Esophageal Submucosal Tumors: A Meta-Analysis.Digestive diseases and sciences · 2026Pooled it
- Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Subepithelial Lesions: A Systematic Review and Meta-Analysis.Journal of gastrointestinal cancer · 2025Pooled it
- Endoscopic resection of esophageal and gastric submucosal tumors from the muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation: A systematic review and meta-analysis.Surgical endoscopy · 2021Pooled it
- Efficacy and Safety Analysis of Submucosal Tunnel Endoscopic Resection for Submucosal Masses in Esophageal Muscularis Propria.Computational and mathematical methods in medicine · 2022Trial
- Submucosal tunneling endoscopic resection in challenging esophageal subepithelial lesions: a minimally invasive approach.iGIE : innovation, investigation and insights · 2026Article
- Feasibility and Safety of Submucosal Tunneling Endoscopic Resection in One Tunnel for Multiple Esophageal Submucosal Tumors Originating from the Muscularis Propria Layer.Digestive diseases and sciences · 2026Article
- Submucosal tunneling endoscopic resection to treat a large symptomatic esophageal lipoma.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2026Article
- Clinical efficacy of endoscopic resection for subepithelial tumors in the esophagogastric junction and gastric cardia: an observational study.Clinical endoscopy · 2026Article
- Comprehensive evaluation of the learning curve for submucosal tunneling endoscopic resection.Surgical endoscopy · 2026Article
- Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Subepithelial Lesions: Development of a Digital Nomogram.Endoscopy international open · 2026Article
- Endoscopic resection in treatment of intramural esophageal cysts: Retrospective analysis of 67 cases.Endoscopy international open · 2026Article
- Endoscopic management of esophagomediastinal fistula following peroral endoscopic myotomy.Surgical endoscopy · 2025Article
- Expanding the role of endoscopic resection in esophageal gastrointestinal stromal tumors: Insights and challenges.World journal of gastroenterology · 2025Article
- Endoscopic retrograde submucosal tunnel resection for cervical esophageal submucosal tumors via percutaneous gastrostomy: a conceptual approach.Frontiers in medicine · 2025Article
- Tips and Thought Processes to Overcome Difficult Situations in Third Space Endoscopy.Current gastroenterology reports · 2024Review
- Comparable long‑term survival outcomes of endoscopic treatment versus surgical treatment for gastrointestinal stromal tumors with a diameter of 5-10 cm.Scientific reports · 2024Article
- A Large Esophageal Leiomyoma: Thoraco-Laparoscopic Enucleation or Esophagectomy and Reconstruction?The American journal of case reports · 2023Article
- Efficacy and safety of submucosal tunneling endoscopic resection for subepithelial tumors in the upper GI tract: a systematic review and meta-analysis of >2900 patients.iGIE : innovation, investigation and insights · 2023Article
- Updates in the Field of Submucosal Endoscopy.Life (Basel, Switzerland) · 2022Review
- A scoring system to support surgical decision-making for cardial submucosal tumors.Endoscopy international open · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the effectiveness and safety of submucosal tunneling endoscopic resection (STER) and compare its outcomes in esophageal and cardial submucosal tumors (SMTs) of the muscularis propria (MP) layer.
methodsFrom May 2012 to November 2017, 173 consecutive patients with upper gastrointestinal (GI) SMTs of the MP layer underwent STER. Overall, 165 patients were included, and 8 were excluded. The baseline characteristics of the patients and SMTs were recorded. The
resultsOne hundred and twelve men and 53 women with a mean age of 46.9 ± 10.8 years were included. The mean tumor size was 22.6 ± 13.6 mm. Eleven SMTs were located in the upper esophagus (6.7%), 49 in the middle esophagus (29.7%), 46 in the lower esophagus (27.9%), and 59 in the cardia (35.7%). Irregular lesions accounted for 48.5% of all lesions. STER achieved an
conclusionSTER is an effective and safe therapy for GI SMTs of the MP layer. Its effectiveness and safety are comparable between SMTs of the esophagus and cardia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.